TrialJAMA network open2025

Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical Trial.

Yuichiro Kikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.